Compare GALT

The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Tuesday's prices. Each symbol is a hyperlink or shortcut to more information.

GALT 0.32%

Profile NASDAQ: GALT $180 Million Small-Cap. Show More

GALT Profile

Market Cap 180 Million
GALT Description

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.

Visit Website

GALT Earnings

EPS -0.06 P/E Ratio --
Previous Fri, Aug 9, 2019
Latest Tue, Nov 12, 2019 (7 days ago) Price -28.24%

GALT Dividend

Yield --
Ex-Date --
Pay Date --
History --

GALT Charts

52 Week Low $2.94 on Fri, Aug 23, 2019.
1 Year
Aug 23, 2019
Feb 21, 2019

Symbol Price Day Ξ” YTD Ξ”
GALT $3.10 0.32% -19.69%


Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy